Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

3155 pGEM-4Z Bcl-2 cDNA G145A Citations (1)

Originally described in: BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax.
Yin XM, Oltvai ZN, Korsmeyer SJ Nature 1994 May 26;369(6478):321-3.
PubMed Journal

Articles Citing 3155 pGEM-4Z Bcl-2 cDNA G145A

Articles
Sphingolipid-based drugs selectively kill cancer cells by down-regulating nutrient transporter proteins. Romero Rosales K, Singh G, Wu K, Chen J, Janes MR, Lilly MB, Peralta ER, Siskind LJ, Bennett MJ, Fruman DA, Edinger AL. Biochem J. 2011 Oct 15;439(2):299-311. doi: 10.1042/BJ20110853. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.